Patients with SSc, clinical manifestations and treatment
| Results are shown as No (%) unless otherwise indicated. | |
| *Blood was drawn before the respective photopheresis cycle after a treatment-free interval of 3 months. | |
| Number of patients | 12 |
| Male/female | 2/10 |
| Age (years), mean (SD) | 54.9 (15.0) |
| Disease duration (years), mean (SD) | 12.4 (3.5) |
| Diffuse SSc | 6 (50) |
| Limited SSc | 6 (50) |
| Organ involvement | |
| Pulmonary fibrosis | 8 (67) |
| Pulmonary hypertension | 3 (25) |
| Oesophageal | 9 (75) |
| Renal | 2 (17) |
| Cardiac | 1 (8) |
| Serological findings | |
| ANA positive | 12 (100) |
| Anti-Scl-70 positive | 5 (42) |
| Anticentromere positive | 1 (8) |
| CRP >10 mg/l | 1 (8) |
| Treatment | |
| Cyclosporin A | 1 (8) |
| Prednisolone ⩽10 mg | 3 (25) |
| Extracorporeal photopheresis* | 5 (42) |